Bedoradrine

Description

Bedoradrine is a highly selective ?2-adrenergic agonist with activity in suppressing asthma and chronic obstructive pulmonary disease COPD . Bedoradrine is administered by intravenous infusion and is specifically indicated for the suppression of acute asthma attacks. Bedoradrine has shown good safety and preliminary efficacy in clinical trials, especially in patients with stable moderate to severe asthma. The results of Bedoradrine studies have shown that it can provide clinical benefits without increasing clinical risks, especially for patients who are unable to use inhalation or nebulization suppression.